Saturday 17 October 2026 Export TLSI’s income statement to Excel — free account

TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $45.2 million, up 53.4% from fiscal 2024. In the quarter to June 2026, revenue grew 1.73%, EPS grew 40.7%, free cash flow fell 41.3% and total debt rose 2.45%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

3.63 0.27 −6.92%

Follow TLSI

Alert me

Market cap: $240.1M
P/E: 0.0×
Fwd P/E: −10.9×
Dividend yield: —
F-score: 3/9
Altman Z: −11.34
Beneish M: −5.08
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	4	3	3	+8 more TTM periods Free account
ROE Full definition →	889.44%	529.28%	233.25%	306.43%
ROA Full definition →	(110.34%)	(114.58%)	(235.03%)	(226.01%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(113.57%)	(97.89%)	(309.01%)	(298.03%)
Average Days of Receivables Full definition →	52.30	42.41	53.01	45.39
Free Cash Flow per Share Full definition →	(0.40)	(0.39)	(0.50)	(0.51)
Free Cash Flow Full definition →	(23.24)	(20.26)	(18.85)	(22.08)
Capital Expenditures Full definition →	(0.44)	(0.26)	(0.84)	(0.85)
Other line items
Cash ROIC Full definition →	(27.06%)	(19.78%)	(96.06%)	(76.87%)
Accounts Receivable Turnover Full definition →	7.49	8.41	7.75	8.11
Accounts Payable Turnover Full definition →	2.26	1.90	2.64	2.45
Inventory Turnover Full definition →	1.60	1.69	1.96	1.76
Average Days of Payables Full definition →	214.41	230.55	157.32	215.17
Days of Inventory on Hand Full definition →	239.59	205.82	161.25	186.28
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	32.45%	33.78%	33.14%	36.87%
Selling, General and Administrative Expense of Revenue Full definition →	121.02%	113.74%	111.11%	124.90%
Share Based Compensation of Revenue Full definition →	23.75%	22.24%	20.22%	21.47%
Interest Coverage Full definition →	(5.23)	(4.86)	(4.86)	(6.06)
Operating CF/Net income Full definition →	0.40	0.35	0.26	0.29
Depreciation/Fixed assets Full definition →	0.95	0.87	0.93	0.90
Capex/Depreciation Full definition →	(0.25)	(0.16)	(0.50)	(0.52)
Revenue per Share Full definition →	0.77	0.87	1.19	0.93
Operating CF per Share Full definition →	(0.39)	(0.39)	(0.48)	(0.49)
Capex per Share Full definition →	(0.01)	(0.01)	(0.02)	(0.02)
Capex to Sales Full definition →	0.01	0.01	0.02	0.02

Show all line items

Columns are period end dates

Stockrow Weekly